Global Measles Attenuated Live Vaccine Market Growth 2026-2032
The global Measles Attenuated Live Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Measles Attenuated Live Vaccine players cover Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Measles Attenuated Live Vaccine Industry Forecast” looks at past sales and reviews total world Measles Attenuated Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Measles Attenuated Live Vaccine sales for 2026 through 2032. With Measles Attenuated Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Attenuated Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Attenuated Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Attenuated Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Measles Attenuated Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Attenuated Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Attenuated Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Attenuated Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Measles Attenuated Live Vaccine players cover Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Measles Attenuated Live Vaccine Industry Forecast” looks at past sales and reviews total world Measles Attenuated Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Measles Attenuated Live Vaccine sales for 2026 through 2032. With Measles Attenuated Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Attenuated Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Attenuated Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Attenuated Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Measles Attenuated Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Attenuated Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Attenuated Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Attenuated Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder
- Liquid
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Pfizer
- Serum Institute of India
- GSK
- Sanofi-Pasteur
- Novartis
- Bavarian Nordic
- Medimmune
- Changchun Keygen Biological Products
- Shanghai Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- What is the 10-year outlook for the global Measles Attenuated Live Vaccine market?
- What factors are driving Measles Attenuated Live Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Measles Attenuated Live Vaccine market opportunities vary by end market size?
- How does Measles Attenuated Live Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles Attenuated Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Measles Attenuated Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Measles Attenuated Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Measles Attenuated Live Vaccine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Measles Attenuated Live Vaccine Sales by Type
2.2.3.1 Global Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Measles Attenuated Live Vaccine Sale Price by Type (2021-2026)
2.3 Measles Attenuated Live Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Measles Attenuated Live Vaccine Sales by Application
2.3.3.1 Global Measles Attenuated Live Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Measles Attenuated Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Measles Attenuated Live Vaccine Breakdown Data by Company
3.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Measles Attenuated Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Measles Attenuated Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Measles Attenuated Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Measles Attenuated Live Vaccine Sale Price by Company
3.4 Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles Attenuated Live Vaccine Product Location Distribution
3.4.2 Players Measles Attenuated Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Measles Attenuated Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Measles Attenuated Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Measles Attenuated Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Measles Attenuated Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Measles Attenuated Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Measles Attenuated Live Vaccine Sales Growth
4.4 APAC Measles Attenuated Live Vaccine Sales Growth
4.5 Europe Measles Attenuated Live Vaccine Sales Growth
4.6 Middle East & Africa Measles Attenuated Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Measles Attenuated Live Vaccine Sales by Country
5.1.1 Americas Measles Attenuated Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Measles Attenuated Live Vaccine Sales by Type (2021-2026)
5.3 Americas Measles Attenuated Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles Attenuated Live Vaccine Sales by Region
6.1.1 APAC Measles Attenuated Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Measles Attenuated Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Measles Attenuated Live Vaccine Sales by Type (2021-2026)
6.3 APAC Measles Attenuated Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles Attenuated Live Vaccine by Country
7.1.1 Europe Measles Attenuated Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Measles Attenuated Live Vaccine Sales by Type (2021-2026)
7.3 Europe Measles Attenuated Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles Attenuated Live Vaccine by Country
8.1.1 Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine
10.3 Manufacturing Process Analysis of Measles Attenuated Live Vaccine
10.4 Industry Chain Structure of Measles Attenuated Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles Attenuated Live Vaccine Distributors
11.3 Measles Attenuated Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Measles Attenuated Live Vaccine Market Size Forecast by Region
12.1.1 Global Measles Attenuated Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Measles Attenuated Live Vaccine Forecast by Type (2027-2032)
12.7 Global Measles Attenuated Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.1.3 Merck Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.4.3 GSK Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi-Pasteur
13.5.1 Sanofi-Pasteur Company Information
13.5.2 Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi-Pasteur Main Business Overview
13.5.5 Sanofi-Pasteur Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.6.3 Novartis Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Information
13.7.2 Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bavarian Nordic Main Business Overview
13.7.5 Bavarian Nordic Latest Developments
13.8 Medimmune
13.8.1 Medimmune Company Information
13.8.2 Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.8.3 Medimmune Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medimmune Main Business Overview
13.8.5 Medimmune Latest Developments
13.9 Changchun Keygen Biological Products
13.9.1 Changchun Keygen Biological Products Company Information
13.9.2 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Changchun Keygen Biological Products Main Business Overview
13.9.5 Changchun Keygen Biological Products Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
13.11 Wuhan Institute of Biological Products
13.11.1 Wuhan Institute of Biological Products Company Information
13.11.2 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wuhan Institute of Biological Products Main Business Overview
13.11.5 Wuhan Institute of Biological Products Latest Developments
13.12 Lanzhou Institute of Biological Products
13.12.1 Lanzhou Institute of Biological Products Company Information
13.12.2 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Lanzhou Institute of Biological Products Main Business Overview
13.12.5 Lanzhou Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles Attenuated Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Measles Attenuated Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Measles Attenuated Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Measles Attenuated Live Vaccine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Measles Attenuated Live Vaccine Sales by Type
2.2.3.1 Global Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Measles Attenuated Live Vaccine Sale Price by Type (2021-2026)
2.3 Measles Attenuated Live Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Measles Attenuated Live Vaccine Sales by Application
2.3.3.1 Global Measles Attenuated Live Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Measles Attenuated Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Measles Attenuated Live Vaccine Breakdown Data by Company
3.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Measles Attenuated Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Measles Attenuated Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Measles Attenuated Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Measles Attenuated Live Vaccine Sale Price by Company
3.4 Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles Attenuated Live Vaccine Product Location Distribution
3.4.2 Players Measles Attenuated Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Measles Attenuated Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Measles Attenuated Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Measles Attenuated Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Measles Attenuated Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Measles Attenuated Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Measles Attenuated Live Vaccine Sales Growth
4.4 APAC Measles Attenuated Live Vaccine Sales Growth
4.5 Europe Measles Attenuated Live Vaccine Sales Growth
4.6 Middle East & Africa Measles Attenuated Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Measles Attenuated Live Vaccine Sales by Country
5.1.1 Americas Measles Attenuated Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Measles Attenuated Live Vaccine Sales by Type (2021-2026)
5.3 Americas Measles Attenuated Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles Attenuated Live Vaccine Sales by Region
6.1.1 APAC Measles Attenuated Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Measles Attenuated Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Measles Attenuated Live Vaccine Sales by Type (2021-2026)
6.3 APAC Measles Attenuated Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles Attenuated Live Vaccine by Country
7.1.1 Europe Measles Attenuated Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Measles Attenuated Live Vaccine Sales by Type (2021-2026)
7.3 Europe Measles Attenuated Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles Attenuated Live Vaccine by Country
8.1.1 Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine
10.3 Manufacturing Process Analysis of Measles Attenuated Live Vaccine
10.4 Industry Chain Structure of Measles Attenuated Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles Attenuated Live Vaccine Distributors
11.3 Measles Attenuated Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Measles Attenuated Live Vaccine Market Size Forecast by Region
12.1.1 Global Measles Attenuated Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Measles Attenuated Live Vaccine Forecast by Type (2027-2032)
12.7 Global Measles Attenuated Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.1.3 Merck Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.4.3 GSK Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi-Pasteur
13.5.1 Sanofi-Pasteur Company Information
13.5.2 Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi-Pasteur Main Business Overview
13.5.5 Sanofi-Pasteur Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.6.3 Novartis Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Information
13.7.2 Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bavarian Nordic Main Business Overview
13.7.5 Bavarian Nordic Latest Developments
13.8 Medimmune
13.8.1 Medimmune Company Information
13.8.2 Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.8.3 Medimmune Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medimmune Main Business Overview
13.8.5 Medimmune Latest Developments
13.9 Changchun Keygen Biological Products
13.9.1 Changchun Keygen Biological Products Company Information
13.9.2 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Changchun Keygen Biological Products Main Business Overview
13.9.5 Changchun Keygen Biological Products Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
13.11 Wuhan Institute of Biological Products
13.11.1 Wuhan Institute of Biological Products Company Information
13.11.2 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Wuhan Institute of Biological Products Main Business Overview
13.11.5 Wuhan Institute of Biological Products Latest Developments
13.12 Lanzhou Institute of Biological Products
13.12.1 Lanzhou Institute of Biological Products Company Information
13.12.2 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Lanzhou Institute of Biological Products Main Business Overview
13.12.5 Lanzhou Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Measles Attenuated Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Measles Attenuated Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Measles Attenuated Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Measles Attenuated Live Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Measles Attenuated Live Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Measles Attenuated Live Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Measles Attenuated Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Measles Attenuated Live Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Measles Attenuated Live Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Measles Attenuated Live Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Measles Attenuated Live Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Measles Attenuated Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Measles Attenuated Live Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Attenuated Live Vaccine Products Offered
Table 22. Measles Attenuated Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Measles Attenuated Live Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Measles Attenuated Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Measles Attenuated Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Measles Attenuated Live Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Measles Attenuated Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Measles Attenuated Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Measles Attenuated Live Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Measles Attenuated Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Measles Attenuated Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Measles Attenuated Live Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Measles Attenuated Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Measles Attenuated Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Measles Attenuated Live Vaccine
Table 52. Key Market Challenges & Risks of Measles Attenuated Live Vaccine
Table 53. Key Industry Trends of Measles Attenuated Live Vaccine
Table 54. Measles Attenuated Live Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Measles Attenuated Live Vaccine Distributors List
Table 57. Measles Attenuated Live Vaccine Customer List
Table 58. Global Measles Attenuated Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Measles Attenuated Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Measles Attenuated Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Measles Attenuated Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Measles Attenuated Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Measles Attenuated Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Measles Attenuated Live Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Measles Attenuated Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Measles Attenuated Live Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Measles Attenuated Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 74. Merck Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Pfizer Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 79. Pfizer Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Serum Institute of India Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. GSK Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 89. GSK Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi-Pasteur Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 94. Sanofi-Pasteur Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi-Pasteur Main Business
Table 96. Sanofi-Pasteur Latest Developments
Table 97. Novartis Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 99. Novartis Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Bavarian Nordic Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 104. Bavarian Nordic Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bavarian Nordic Main Business
Table 106. Bavarian Nordic Latest Developments
Table 107. Medimmune Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 109. Medimmune Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Medimmune Main Business
Table 111. Medimmune Latest Developments
Table 112. Changchun Keygen Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 114. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Changchun Keygen Biological Products Main Business
Table 116. Changchun Keygen Biological Products Latest Developments
Table 117. Shanghai Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 119. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shanghai Institute of Biological Products Main Business
Table 121. Shanghai Institute of Biological Products Latest Developments
Table 122. Wuhan Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 124. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Wuhan Institute of Biological Products Main Business
Table 126. Wuhan Institute of Biological Products Latest Developments
Table 127. Lanzhou Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 129. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Lanzhou Institute of Biological Products Main Business
Table 131. Lanzhou Institute of Biological Products Latest Developments
Table 1. Measles Attenuated Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Measles Attenuated Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Measles Attenuated Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Measles Attenuated Live Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Measles Attenuated Live Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Measles Attenuated Live Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Measles Attenuated Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Measles Attenuated Live Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Measles Attenuated Live Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Measles Attenuated Live Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Measles Attenuated Live Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Measles Attenuated Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Measles Attenuated Live Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Attenuated Live Vaccine Products Offered
Table 22. Measles Attenuated Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Measles Attenuated Live Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Measles Attenuated Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Measles Attenuated Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Measles Attenuated Live Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Measles Attenuated Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Measles Attenuated Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Measles Attenuated Live Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Measles Attenuated Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Measles Attenuated Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Measles Attenuated Live Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Measles Attenuated Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Measles Attenuated Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Measles Attenuated Live Vaccine
Table 52. Key Market Challenges & Risks of Measles Attenuated Live Vaccine
Table 53. Key Industry Trends of Measles Attenuated Live Vaccine
Table 54. Measles Attenuated Live Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Measles Attenuated Live Vaccine Distributors List
Table 57. Measles Attenuated Live Vaccine Customer List
Table 58. Global Measles Attenuated Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Measles Attenuated Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Measles Attenuated Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Measles Attenuated Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Measles Attenuated Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Measles Attenuated Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Measles Attenuated Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Measles Attenuated Live Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Measles Attenuated Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Measles Attenuated Live Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Measles Attenuated Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 74. Merck Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Pfizer Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 79. Pfizer Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Serum Institute of India Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. GSK Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 89. GSK Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sanofi-Pasteur Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 94. Sanofi-Pasteur Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi-Pasteur Main Business
Table 96. Sanofi-Pasteur Latest Developments
Table 97. Novartis Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 99. Novartis Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Bavarian Nordic Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 104. Bavarian Nordic Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Bavarian Nordic Main Business
Table 106. Bavarian Nordic Latest Developments
Table 107. Medimmune Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 109. Medimmune Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Medimmune Main Business
Table 111. Medimmune Latest Developments
Table 112. Changchun Keygen Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 114. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Changchun Keygen Biological Products Main Business
Table 116. Changchun Keygen Biological Products Latest Developments
Table 117. Shanghai Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 119. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shanghai Institute of Biological Products Main Business
Table 121. Shanghai Institute of Biological Products Latest Developments
Table 122. Wuhan Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 124. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Wuhan Institute of Biological Products Main Business
Table 126. Wuhan Institute of Biological Products Latest Developments
Table 127. Lanzhou Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 129. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Lanzhou Institute of Biological Products Main Business
Table 131. Lanzhou Institute of Biological Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Measles Attenuated Live Vaccine
Figure 2. Measles Attenuated Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Attenuated Live Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Measles Attenuated Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Measles Attenuated Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Measles Attenuated Live Vaccine Sales Market Share by Type in 2026
Figure 14. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Measles Attenuated Live Vaccine Consumed in Hospital
Figure 16. Global Measles Attenuated Live Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Measles Attenuated Live Vaccine Consumed in Clinic
Figure 18. Global Measles Attenuated Live Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Measles Attenuated Live Vaccine Sale Market Share by Application (2025)
Figure 20. Global Measles Attenuated Live Vaccine Revenue Market Share by Application in 2026
Figure 21. Measles Attenuated Live Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Measles Attenuated Live Vaccine Sales Market Share by Company in 2026
Figure 23. Measles Attenuated Live Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Measles Attenuated Live Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Measles Attenuated Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Measles Attenuated Live Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Measles Attenuated Live Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Measles Attenuated Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Measles Attenuated Live Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Measles Attenuated Live Vaccine
Figure 73. Industry Chain Structure of Measles Attenuated Live Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Measles Attenuated Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Measles Attenuated Live Vaccine
Figure 2. Measles Attenuated Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Attenuated Live Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Measles Attenuated Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Measles Attenuated Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Measles Attenuated Live Vaccine Sales Market Share by Type in 2026
Figure 14. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Measles Attenuated Live Vaccine Consumed in Hospital
Figure 16. Global Measles Attenuated Live Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Measles Attenuated Live Vaccine Consumed in Clinic
Figure 18. Global Measles Attenuated Live Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Measles Attenuated Live Vaccine Sale Market Share by Application (2025)
Figure 20. Global Measles Attenuated Live Vaccine Revenue Market Share by Application in 2026
Figure 21. Measles Attenuated Live Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Measles Attenuated Live Vaccine Sales Market Share by Company in 2026
Figure 23. Measles Attenuated Live Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Measles Attenuated Live Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Measles Attenuated Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Measles Attenuated Live Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Measles Attenuated Live Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Measles Attenuated Live Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Measles Attenuated Live Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Measles Attenuated Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Measles Attenuated Live Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Measles Attenuated Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Measles Attenuated Live Vaccine
Figure 73. Industry Chain Structure of Measles Attenuated Live Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Measles Attenuated Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
